🇺🇸 FDA
Patent

US 9109036

Immunogenic composition comprising alpha-hemolysin oligopeptides

granted A61KA61K2039/505A61K2039/55505

Quick answer

US patent 9109036 (Immunogenic composition comprising alpha-hemolysin oligopeptides) held by INTEGRATED BIOTHERAPEUTICS, INC. expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INTEGRATED BIOTHERAPEUTICS, INC.
Grant date
Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K2039/55505, A61K2039/55572, A61K38/00